Trial intelligence / Profile preview

High-concentration PRP injection for thumb base osteoarthritis pain

NL-OMON58338Recruiting

Sponsor
Goed Medisch Centrum
Start
May 2026
Countries
1
01

Overview

Randomised, double-blind trial of platelet-rich plasma in Rhizarthrosis and osteoarthritis (OA) (2 arms), sponsored by Goed Medisch Centrum. Primary endpoint: Pain improvement at 12 months. Started May 2026; status: recruiting.

02

Drugs

platelet-rich plasma
03

Conditions

Rhizarthrosisosteoarthritis (OA)

Beyond the preview

Go deeper on NL-OMON58338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON58338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call